Reply: To PMID 24242357.
US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD.
Andrew J
AJ
Fine
Alfred
A
Sorbello
Cindy
C
Kortepeter
D016907:Adverse Drug Reaction Reporting Systems / Q000639:trends*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D028761:Withholding Treatment / Q000639:trends*
D061067:Antibodies, Monoclonal, Humanized